Literature DB >> 30442592

Improvement of a rapid direct blood culture microbial identification protocol using MALDI-TOF MS and performance comparison with SepsiTyper kit.

Francesca Di Gaudio1, Serena Indelicato2, Sergio Indelicato3, Maria Rita Tricoli3, Giuseppe Stampone3, David Bongiorno2.   

Abstract

Fast diagnosis of pathogens is critical to guarantee the most adequate therapy for infections; bacterial culture methods, which constitute the actual gold standard, are precise and sensitive but rather slow. Today, new methods have been made available to enable faster diagnosis, with the Matrix-Assisted Laser Desorption Ionization-Time Of Flight Mass Spectrometry (MALDI-TOF MS) technique being the most promising. Even if simpler and faster than traditional bacterial culture methods, analysis of positive blood cultures via MALDI-TOF MS requires a preliminary extraction process of samples. In this study, we compared two extraction protocols for bacterial identification directly from positive blood cultures using the Bruker MALDI Biotyper system (Bruker Daltonics, Billerica, MA). In particular, we evaluated the time employed and the overall performance for their accurate identification. In this work, the performances of a commercial extraction kit, named SepsiTyper™ Kit, and those of the protocol developed by Treibmann et al. were evaluated and proven to be similar. However, the SELTERS method represents the best compromise price/performance. Lastly, an in-house developed analysis protocol has been tested, and the introduced optimizations granted a performance level equal if not better than the SepsiTyper kit, a reduced processing time and reduced costs.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacteria; Clinical diagnostic laboratory; Genus and species identification; Matrix- assisted laser desorption ionization time of flight mass spectrometry; Pathogens identification

Mesh:

Year:  2018        PMID: 30442592     DOI: 10.1016/j.mimet.2018.10.015

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  6 in total

1.  Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study.

Authors:  Catherine Anne Hogan; Bertrand Ebunji; Nancy Watz; Kristopher Kapphahn; Joseph Rigdon; Emily Mui; Lina Meng; William Alegria; Marisa Holubar; Stanley Deresinski; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

2.  The Distribution and Source of MRDOs Infection: A Retrospective Study in 8 ICUs, 2013-2019.

Authors:  Zhan-Jie Li; Ke-Wei Wang; Bo Liu; Feng Zang; Yu Zhang; Wei-Hong Zhang; Su-Ming Zhou; Yong-Xiang Zhang
Journal:  Infect Drug Resist       Date:  2021-11-27       Impact factor: 4.003

3.  Evaluation of Rapid Sepsityper® protocol and specific MBT-Sepsityper module (Bruker Daltonics) for the rapid diagnosis of bacteremia and fungemia by MALDI-TOF-MS.

Authors:  Léa Ponderand; Patricia Pavese; Danièle Maubon; Emmanuelle Giraudon; Thomas Girard; Caroline Landelle; Max Maurin; Yvan Caspar
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-12-09       Impact factor: 3.944

4.  Evaluation of a Rapid and Simplified Protocol for Direct Identification of Microorganisms From Positive Blood Cultures by Using Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS).

Authors:  Yufeng Dai; Xinyi Xu; Xue Yan; Daming Li; Wei Cao; Lingli Tang; Min Hu; Chuanhao Jiang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-11       Impact factor: 5.293

5.  Risk Factors for a Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection: A Five-Year Retrospective Study.

Authors:  Zubai Cao; Chengcheng Yue; Qinxiang Kong; Yanyan Liu; Jiabin Li
Journal:  Infect Drug Resist       Date:  2022-02-25       Impact factor: 4.003

6.  Optimized identification of microorganisms directly from positive blood cultures by MALDI-TOF to improve antimicrobial treatment.

Authors:  P García Clemente; P Romero-Gómez; J García-Rodríguez; E Cendejas-Bueno
Journal:  Rev Esp Quimioter       Date:  2022-05-23       Impact factor: 2.515

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.